Skip to content

Hemodynamic Responses to Enhanced External Counterpulsation with Different Positions in Coronary Artery Disease

Hemodynamic Responses to Enhanced External Counterpulsation with Different Positions in Coronary Artery Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087057
Enrollment
Unknown
Registered
2024-07-18
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Experimental group:position change

Sponsors

The Eighth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Subjects with stable coronary heart disease who have objective evidence of ischemia (coronary stenosis =50% confirmed by coronary angiography or coronary CTA) and stable symptoms (angina grading CCSI~II), complete revascularization, and have received standard drug therapy for coronary heart disease for more than 4 weeks; ?30-75 years old; ? No EECP treatment in the past 3 months.

Exclusion criteria

Exclusion criteria: ? Severe aortic valve insufficiency; ? Dissecting aneurysm; ? Significant pulmonary arterial hypertension; ? Various bleeding disorders or bleeding tendencies, or use of anticoagulants, INR>2.0; ? Various heart valve diseases or congenital heart diseases with heart failure; ? Active phlebitis and venous thrombosis cannot be treated together; ? There are infection foci in the limbs; ? Uncontrolled hyperglycemia (170/110mmHg); ? Uncontrolled arrhythmia; ? Acute myocarditis and pericarditis; ? Symptomatic aortic stenosis; ? Severe obstructive hypertrophic cardiomyopathy; ? Acute or severe heart failure; ? CCSIV angina pectoris ; ? Pregnancy; Other serious illnesses or limb movement disorders that affect movement; ? EF<50%; ? Unable to cooperate with treatment or research plan; ? Those who have participated in other research projects in the past three months;

Design outcomes

Primary

MeasureTime frame
D/S ratio;

Secondary

MeasureTime frame
cardiac output;cardiac index;Stroke volume;Stroke volume index;Peripheral vascular resistance;Peripheral vascular resistance index;

Countries

China

Contacts

Public ContactGuifu Wu

The Eighth Affiliated Hospital of Sun Yat-sen University

wuguifu@mail.sysu.edu.cn+86 159 8989 3111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026